# Clinical Pharmacology K12 Training Program

> **NIH NIH K12** · CINCINNATI CHILDRENS HOSP MED CTR · 2024 · $297,000

## Abstract

PROJECT SUMMARY/ABSTRACT
During the past 20 years, Congress, the National Institutes of Health (NIH), and the Food and Drug
Administration (FDA) have made it clear that safe drug therapy for children is a high priority. With the rapidly
changing health care and research environments, it has become essential to focus on the training of the next
generation of leaders in Pediatric Clinical Pharmacology who are involved in the design and conduct of hands-
on drug studies in children to augment the translation of new and effective therapies for children. The proposed
Cincinnati Children’s Pediatric Clinical Pharmacology K12 program aims to provide the resources for a diverse
group of junior faculty to become the next leaders in Pediatric Clinical Pharmacology. This includes training in
the principles of Pediatric Clinical Pharmacology to those who may never had previous clinical pharmacology
experience while also facilitating the transition from fellowship to junior faculty to independent investigator for
those who have had previous fellowship training in Pediatric Clinical Pharmacology. The training program we
propose in this application for K12 Scholars will leverage the outstanding research infrastructure that exists within
Cincinnati Children’s Hospital Medical Center and the University of Cincinnati Academic Health Center, the
strong research training activities that we have built within the Cincinnati Children’s Division of Clinical
Pharmacology, and the robust collaborations that our Division has developed with other Clinical Pharmacology
T32 sites and Clinical Pharmacology programs throughout the nation. Through our rigorous training program,
we expect Scholars to achieve the following five core competencies: 1) Foundational Knowledge and Skill in
Pharmacometrics, 2) Foundational Knowledge and Skills in Pharmacogenetics, 3) In-depth Understanding of the
Impact of Developmental Pharmacology Principles on Drug Action and Toxicity, 4) Ability to Conduct Studies in
a Variety of Pediatric Patient Populations, and 5) Collaborative Skills in Interdisciplinary Team Research. The
four pillars of training to achieve these core competencies will be focused on 1) research training, 2) responsible
conduct of research, 3) teaching/research mentorship and 4) leadership and career development through both
experiential learning and didactic courses with knowledge and skills to be attained and expected outcomes in
each of these areas. Intended Scholar outcomes include high impact manuscripts describing research in
Pediatric Clinical Pharmacology, submission of independent K career development awards or R awards, delivery
of lectures and presentations on clinical pharmacology topics in local forums and national conferences,
experience in mentoring trainees locally and nationally, and leadership positions in national committees in
Clinical Pharmacology societies. We intend to have two junior faculty Scholars appointed at any time with the
anticipated appointments...

## Key facts

- **NIH application ID:** 10892271
- **Project number:** 5K12HD113190-02
- **Recipient organization:** CINCINNATI CHILDRENS HOSP MED CTR
- **Principal Investigator:** TRACY A GLAUSER
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $297,000
- **Award type:** 5
- **Project period:** 2023-08-01 → 2028-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10892271

## Citation

> US National Institutes of Health, RePORTER application 10892271, Clinical Pharmacology K12 Training Program (5K12HD113190-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10892271. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*